Cellectar biosciences stock price

Cellectar Reports Financial Results for Year Ended December 31, 2019 and Provides a Corporate Update. FLORHAM PARK, N.J., March 09, 2020 -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and. Cellectar Biosciences, Inc. (CLRB) Earnings Report ...

CLRB Stock Quote - Cellectar BioSciences, Inc. Stock Price ... CLRB stock quote, chart and news. Get Cellectar BioSciences, Inc.'s stock price today. Cellectar Biosciences, Inc. Common Stock (CLRB) Real-Time ... CLRB Real Time Stock Quote - Get Cellectar Biosciences, Inc. Common Stock (CLRB) last sale data in real-time at NASDAQ.com. CLRB Stock Price Quote & News - Cellectar Biosciences ... View the real-time CLRB price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Cellectar Biosciences against related stocks people have also bought like NIO, GERN, ACB, and OGEN. 869 people own Cellectar Biosciences on Robinhood on April 4, 2020. NV4P:Frankfurt Stock Quote - Cellectar Biosciences Inc ...

Cellectar Biosciences stock surges 23% premarket MarketWatch. Tuesday, July 17, 2018. 01:26 PM ET. Cellectar Biosciences shares surge 15% on results of one cancer patient in mid-stage trial MarketWatch. Wednesday, June 15, 2016. 09:16 AM ET. Cellectar's stock soars after positive results of a study of its tumor treatment MarketWatch. More

Cellectar Reports Financial Results for Year Ended December 31, 2019 and Provides a Corporate Update. FLORHAM PARK, N.J., March 09, 2020 -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and. Cellectar Biosciences Stock Quote: CLRB Stock News, Quotes ... Nov 08, 2019 · CLRB, Cellectar Biosciences - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Cellectar Biosciences Stock Quote: CLRB Stock News, Quotes, Analysis | Investors.com CELLECTAR BIOSCIENCES, INC. - CLRBD - Stock Price & News ...

In depth view into CLRB (Cellectar Biosciences) stock including the latest price, news, dividend history, earnings information and financials.

Historical daily share price chart and data for Cellectar Biosciences since 2020 adjusted for splits. The latest closing stock price for Cellectar Biosciences as of  The Cellectar Biosciences stock price is 1.190 USD today. Will Cellectar Biosciences stock price grow / rise / go up? Yes. The CLRB stock price can go up from  Stock analysis for Cellectar Biosciences Inc (CLRB:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company  Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes   CLRB Cellectar Biosciences, Inc. daily Stock Chart Book/sh, 0.84, P/B, 1.40, EPS next Y, 15.60%, ROA, -94.60%, Target Price, 6.35, Perf Year, -51.65%. Cash /  Cellectar Biosciences Inc (CLRBZ) Stock Quote and detailed dividend history including dividend dates, yield, company news, and key financial metrics. Cellectar Biosciences (Nasdaq: CLRB) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and 

Cellectar Biosciences, Inc. Series A Warrants (CLRBZ) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

CLRB:NASDAQ CM Stock Quote - Cellectar Biosciences Inc ... Stock analysis for Cellectar Biosciences Inc (CLRB:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. CLRB Stock Quote - Cellectar Biosciences, Inc. Common ... Mar 30, 2020 · Stock quote for Cellectar Biosciences, Inc. Common Stock Common Stock (CLRB) with real-time last sale and extended hours stock prices, company news, charts, and research at Nasdaq. CLRB - Cellectar Biosciences Summary, Stock Quote and News ...

CLRB | Stock Snapshot - Fidelity

9:00a Carnival stock price target raised to $62 from $57 at Stifel Nicolaus. 9:00a KLA stock price target raised to $170 from $151 at Stifel Nicolaus. 9:00a Why the Saudi oil attack is a ‘big deal’ that could be a ‘game changer’ in stock markets and crude prices. Cellectar Biosciences, Inc. (CLRB) Stock Price, Quote ... Find the latest Cellectar Biosciences, Inc. (CLRB) stock quote, history, news and other vital information to help you with your stock trading and investing.

Cellectar Biosciences, Inc. (CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the  Real-time trade and investing ideas on Cellectar Biosciences, Inc. CLRB from the largest community of traders and investors. CLRB | Complete Cellectar Biosciences Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.